Advertisement

Table of Contents

December 01, 1985; Volume 28,Issue 6

You have access
[3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
A B Norman, G Battaglia and I Creese

Molecular Pharmacology December 1985, 28 (6) 487-494;
You have access
Desensitization and resensitization of beta-adrenergic receptors in a smooth muscle cell line.
P J Scarpace, L A Baresi, D A Sanford and I B Abrass

Molecular Pharmacology December 1985, 28 (6) 495-501;
You have access
Forskolin potentiation of cholera toxin-stimulated cyclic AMP accumulation in intact C6-2B cells. Evidence for enhanced Gs-C coupling.
K Barovsky and G Brooker

Molecular Pharmacology December 1985, 28 (6) 502-507;
You have access
Activation of human blood platelets by arginine-vasopressin. Role of bivalent cations.
A Pletscher, P Erne, E Bürgisser and F Ferracin

Molecular Pharmacology December 1985, 28 (6) 508-514;
You have access
Effects of apomorphine enantiomers and of lisuride on 3,4-dihydroxyphenylalanine production in striatal synaptosomes.
M Bräutigam, B Kittner and G Laschinski

Molecular Pharmacology December 1985, 28 (6) 515-520;
You have access
Angiotensin-converting enzyme inhibitors potentiate the analgesic activity of [Met]-enkephalin-Arg6-Phe7 by inhibiting its degradation in mouse brain.
J A Norman, W L Autry and B S Barbaz

Molecular Pharmacology December 1985, 28 (6) 521-526;
You have access
The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex.
K P Shaw, Y Aracava, A Akaike, J W Daly, D L Rickett and E X Albuquerque

Molecular Pharmacology December 1985, 28 (6) 527-538;
You have access
An inhibitory monoclonal antibody to rabbit brain acetylcholinesterase. Studies on interaction with the enzyme.
S Brimijoin, K P Mintz and F G Prendergast

Molecular Pharmacology December 1985, 28 (6) 539-545;
You have access
Stimulation of lipoxygenase product synthesis in human leukocytes and platelets by melittin.
H Salari, P Braquet and P Borgeat

Molecular Pharmacology December 1985, 28 (6) 546-548;
You have access
Arachidonic acid stimulates phosphoinositide hydrolysis and human placental lactogen release in an enriched fraction of placental cells.
P Zeitler and S Handwerger

Molecular Pharmacology December 1985, 28 (6) 549-554;
You have access
The reaction between organic nitrates and sulfhydryl compounds. A possible model system for the activation of organic nitrates.
R A Yeates, H Laufen and M Leitold

Molecular Pharmacology December 1985, 28 (6) 555-559;
You have access
Relationship between the oxidation potential of benzene metabolites and their inhibitory effect on DNA synthesis in L5178YS cells.
P Pellack-Walker, J K Walker, H H Evans and J L Blumer

Molecular Pharmacology December 1985, 28 (6) 560-566;
You have access
Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
J A Sokoloski and A C Sartorelli

Molecular Pharmacology December 1985, 28 (6) 567-573;
You have access
Effects of hydroxyurea and thymidine derivatives on the uptake and metabolism of deoxycytidine and arabinofuranosylcytosine in log phase and contact-inhibited human diploid fibroblasts.
R D Snyder and N C Malick

Molecular Pharmacology December 1985, 28 (6) 574-580;
You have access
Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
J Balzarini, E De Clercq, A Verbruggen, D Ayusawa and T Seno

Molecular Pharmacology December 1985, 28 (6) 581-587;
You have access
Binding of a synthetic beta-endorphin peptide to calmodulin.
D P Giedroc and D Puett

Molecular Pharmacology December 1985, 28 (6) 588-593;